Latest Translational medicine Stories
SANTA CLARA, Calif., April 30, 2013 /PRNewswire/ -- NextBio today announced a multi-year collaboration with Sanofi (NYSE:SNY) aimed at using NextBio Clinical to incorporate patient omics and clinical data into Sanofi's drug research and development, as part of Sanofi's Translational Medicine for Patients (TM4P) program. (Logo: http://photos.prnewswire.com/prnh/20130402/SF86976LOGO) NextBio will provide Sanofi with the NextBio Clinical platform for aggregation, standardization and...
Garret FitzGerald, MD, FRS, chair of the Department of Pharmacology and Director of the Institute for Translational Medicine & Therapeutics, Perelman School of Medicine at the University of Pennsylvania, has long said the current drug-development system in the United States is in need of change, "representing an unsustainable model." Even though the number of drugs approved has risen in the last three years, overall, roughly the same number of drugs have been approved by the Food and...
ELLICOTT CITY, Md., Oct. 15, 2012 /PRNewswire/ -- The Society for Clinical Research Sites (SCRS) was unveiled during the 7(th) Annual Site Solutions Summit on October 13, 2012. SCRS was founded in response to the growing need for a trade organization to represent the voice of clinical research sites within the clinical research enterprise. The Society's mission is to Unify and amplify the voice of the global clinical research site community. Christine Pierre, founder...
Ignyta’s vision is to kindle the development and usage of the most accurate molecular diagnostic tests and precisely targeted therapeutics in autoimmune diseases (AID) and to extinguish AID through earlier, more enlightened diagnosis and treatment of patients worldwide. San Diego, CA (PRWEB) October 09, 2012 NexDx, Inc. announced today that it has changed its name to Ignyta, Inc. The name change reflects the San Diego based biotechnology company’s broader commitment to catalyzing the...
PASADENA, Calif., Sept. 20, 2012 /PRNewswire/ -- Alexandria Real Estate Equities, Inc. (NYSE: ARE), the leading owner, operator, and developer of high-quality, sustainable real estate for the broad and diverse life science industry, is honored to announce that Roche Holding Ltd will establish its new Translational Clinical Research Center (TCRC) at the Alexandria Center for Life Science - New York City. The TCRC will be the mission-critical presence for Roche Pharma Research and...
MORGANTOWN, W.Va., Aug. 15, 2012 /PRNewswire-USNewswire/ -- The Robert C. Byrd Health Sciences Center of West Virginia University has been awarded a $19.6 million grant from the National Institutes of Health (NIH) that will be used to address the health issues that most commonly affect West Virginians. The grant to the West Virginia Clinical and Translational Science Institute (WVCTSI) is part of the NIH Institutional Development Award Program for Clinical and Translational Research...
WASHINGTON, July 13, 2012 /PRNewswire-iReach/ -- Science Translational Medicine, the newest journal from the American Association for the Advancement of Science (AAAS), and the Days of Molecular Medicine Global Foundation (DMM GF) announced today the launch of Days of Molecular Medicine 2012 "The Translational Science of Rare Diseases: From Rare to Care," a three-day meeting which will be held in Vienna, Austria from October 8 through October 10, 2012. Taking place at the Palais de...
Denmark organizes executive roundtable at Bio 2012 Conference to highlight the Danish success of using translational medicine to bring new drugs faster to market. NEW YORK, June 15, 2012 /PRNewswire-USNewswire/ -- The following is being released by Invest in Denmark, North America: The increasing global demand for higher quality and more efficient healthcare at lower costs will benefit patients, payers, and providers. An essential part of the roadmap to better healthcare is...
SALT LAKE CITY, May 11, 2012 /PRNewswire/ -- Remedy Informatics, Inc. further strengthened its position as the leader in life science and translational research informatics today with its announcement of revolutionary new biorepository informatics software, SpecimenTrack(TM). Remedy will offer demonstrations of SpecimenTrack at the upcoming International Society for Biological and Environmental Repositories (ISBER) 2012 Annual Meeting & Exhibit May 15-17, in Vancouver, BC,...
SALT LAKE CITY, May 3, 2012 /PRNewswire/-- Remedy Informatics, Inc., the leading provider of registries for Life Science and Translational research, today announced that is has been named a "Cool Vendor" in the Life Sciences, 2012(1), by Gartner, Inc. Remedy was also recently mentioned in two other important Gartner research reports, "Convergence of Healthcare Information Creates Opportunities for Life Sciences,"(2) and "Translational Medicine Still Has Barriers for Connecting Life...
